About Winzetta
Winzetta is a company based in India. It operates as a B2B and D2C. Winzetta offers products and services including Cardiology Products, Diabetology Products, Nephrology Products, Psychiatry Products, and Gastroenterology Products.
- Headquarter India
- Employees 18
- SectorsHealthcare
- Email••••••••
- Website winzetta.in
- Legal Name Winzetta Pharma Private Limited
- Date of Incorporation 14 May, 2021
- Jurisdiction Derebail Konchady Mangalore, Karnataka, India
- Annual Revenue₹2.58 Cr
FY 2024 · +53% YoY
- Net Profit₹20.6 Lakh
FY 2024 · 8% margin
- EBITDA₹21.5 Lakh
FY 2024 · 8% margin
- Employee Count18
Associated legal entities of Winzetta
Winzetta operates through Winzetta Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Winzetta Pharma Private Limited CIN U24299KA2021PTC147446 | Active | 14 May 2021 | Mangalore, Karnataka | ₹2.6 Cr | 18 | 5 | View details |
Products & Services of Winzetta
Winzetta offers a comprehensive portfolio of products and services, including Cardiology Products, Diabetology Products, Nephrology Products, Psychiatry Products, and Gastroenterology Products.
Medicines for heart conditions and related treatments.
Treatments for diabetes management and control.
Drugs for kidney disorders and renal care.
Medications for mental health and disorders.
Solutions for digestive system issues.
Board of directors of Winzetta Pharma Private Limited (Winzetta)
Winzetta Pharma Private Limited is the primary company behind Winzetta. The board of Winzetta Pharma Private Limited currently have 5 directors; the longest-serving is Koteshwara Srinivasarao Kumar, appointed in 2021. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Koteshwara Srinivasarao Kumar DIN 06908291 | Director | 14 May 2021 | 5 yrs 4 mo | Winzetta Pharma Private Limited |
| Halemelige Prahladarao Raviraj DIN 06909671 | Director | 14 May 2021 | 5 yrs 4 mo | Winzetta Pharma Private Limited |
| Adiga Gopalkrishna DIN 09851404 | Director | 13 Mar 2023 | 3 yrs 6 mo | Winzetta Pharma Private Limited |
| Balakrishna Shetty DIN 09851403 | Director | 13 Mar 2023 | 3 yrs 6 mo | Winzetta Pharma Private Limited |
| Vigneshwara Adiga DIN 02454146 | Director | 13 Mar 2023 | 3 yrs 6 mo | Winzetta Pharma Private Limited |
Financials of Winzetta
Figures of Winzetta Pharma Private Limited, the primary company behind Winzetta, for FY 2024. Revenue was ₹2.58 Cr (+53% year on year). Net profit was ₹20.6 Lakh (8% margin). EBITDA was ₹21.5 Lakh (8% margin).
- ₹2.58 CrRevenue · FY 2024 · +53% YoY
- ₹20.6 LakhNet profit · 8% margin
- ₹21.5 LakhEBITDA · 8% margin
- ₹10 LakhPaid-up capital
- 18Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Winzetta Pharma Private Limited are on its company page.
Detailed financial statements for Winzetta
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Winzetta
10 companies that operate in the same segment as Winzetta (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Winzetta
Winzetta is headquartered in India.
Winzetta has 18 employees.
The primary company behind Winzetta, Winzetta Pharma Private Limited, reported revenue of ₹2.58 Cr for FY 2024, up 53% year on year.
Winzetta Pharma is a pharmaceutical company dedicated to supplying quality medicines at affordable costs, emphasizing expertise, innovation, and ethical practices. They operate with a skilled team of professionals to ensure product safety and efficacy across various medical areas. Based in Mangalore, India, the company focuses on global reach through responsible entrepreneurship and serves healthcare needs in cardiology, nephrology, and more, benefiting communities worldwide.
Winzetta offers Cardiology Products, Diabetology Products, Nephrology Products, Psychiatry Products, and Gastroenterology Products.
Winzetta operates through Winzetta Pharma Private Limited.
The legal entities of Winzetta currently have 5 directors, including Koteshwara Srinivasarao Kumar, Halemelige Prahladarao Raviraj, Adiga Gopalkrishna and others.